Michael J. Donovan - 01 Jul 2023 Form 3 Insider Report for Renalytix plc (RNLXY)

Role
Chief Medical Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
RNLXY
Transactions as of
01 Jul 2023
Net transactions value
$0
Form type
3
Filing time
03 Jul 2023, 16:19:38 UTC
Next filing
07 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RNLX Employee Stock Option (right to buy) 01 Jul 2023 Ordinary Shares 269,081 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 The exercise price is 1.21 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.53 using the Bank of England rate as of June 29, 2023 (1.00 pound sterling = $1.262).

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney